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Stem cell survival after transplantation determines the efficiency of stem cell treatment, which develops as a novel potential therapy
for several central nervous system (CNS) diseases in recent decades. The engrafted stem cells face the damage of oxidative stress,
inflammation, and immune response at the lesion point in host. Among the damaging pathologies, oxidative stress directs stem
cells to apoptosis and even death through several signalling pathways and DNA damage. However, the in-detail mechanism of stem
cell survival from oxidative stress has not been revealed clearly. Here, in this study, we used hydrogen peroxide (H
2
O
2
) to induce
the oxidative damage on neural stem cells (NSCs). The damage was in consequence demonstrated involving the activation of heat
shock protein 90 (HSP90) and NF-𝜅B/p65 signalling pathways. Further application of the pharmacological inhibitors, respectively,
targeting at each signalling indicated an upper-stream role of HSP90 upon NF-𝜅B/p65 on NSCs survival. Preinhibition of HSP90
with the specific inhibitor displayed a significant protection on NSCs against oxidative stress. In conclusion, inhibition of HSP90
would attenuate NF-𝜅B/p65 activation by oxidative induction and promote NSCs survival from oxidative damage.TheHSP90/NF-
𝜅B mechanism provides a new evidence on rescuing NSCs from oxidative stress and also promotes the stem cell application on
CNS pathologies.
1. Introduction
Stem cell transplantation is considered as a novel potential
therapy for several central nervous system (CNS) diseases
through both growth/trophic factor support and neural cell
replacement [1–3]. However, the dramatic number of cell
death after transplantation due to oxidative stress, inflam-
mation, and immune response in lesion limits the therapy
for wide application [4–7]. To increase the stem cell survival
after transplantation, strategies against the above damaging
pathologies are investigated in recent decades [8].
Among the damaging pathologies, oxidative stress is con-
sidered as a primary vital damaging factor to engrafted stem
cells. The pathology directs the stem cells to produce extra
reactive oxygen species (ROS), which could trigger several
of intracellular signalling cascades, thus leading to DNA
damage and cell apoptosis and even death [9]. Therefore,
study on the underlying signalling mechanism in oxidative
stress could provide some evidence to rescue the engrafted
stem cells from damage. Previous study of ours reported
the mediating role of NF-𝜅B/p65 in neuronal protection
against oxidative stress [10]while bothwhether this signalling
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transduction also applies on NSCs survival and the pathway
from oxidative stimulation to NF-𝜅B/p65 activation in NSCs
have not been investigated before.
In this study, we investigated the role of heat shock
protein 90 (HSP90) and NF-𝜅B/p65 in neural stem cells
(NSCs) under induced oxidative injury, as well as their
relationship during the pathology. According to our results,
oxidative stress firstly triggers HSP90 in stimulated NSCs.
The triggered HSP90 in consequence activates NF-𝜅B/p65
through IKK/I𝜅B/p65 cascade, which leads finally to cell
death. Inhibiting HSP90 activity will block the downstream
activation of NF-𝜅B/p65 under oxidative stress and increase
NSCs survival. The HSP90/NF-𝜅B mechanism might rescue
NSCs from oxidative stress and also promotes the stem cell
study and application on CNS pathology.
2. Material and Methods
2.1. Reagents. DMEM/F12, B27 supplement, EGF, bFGF, Pen-
icillin/Streptomycin,Accutase, Poly-D-lysine (PDL), andAn-
nexin V-FITC/PI kit were purchased from Thermo Fisher
Scientific (San Jose, CA, USA). Hydrogen Peroxide (H
2
O
2
),
DMSO, Geldanamycin (GA), JSH-23, and MTT were pur-
chased from Sigma-Aldrich (St. Louis, MO, USA). All pri-
mary antibodies used in this study were purchased from
Cell Signalling Technology (Danvers, MA, USA). Goat anti-
rabbit/mouse IgG (H+L)Alexa Fluor 488/594 andHRP con-
jugate secondary antibodies were purchased from Thermo
Fisher Scientific (San Jose, CA, USA). Hoechst 33342 and
DCFH-DA probe were purchased from Beyotime Biotech
(Haimen, China).
2.2. Neural Stem Cell Culture. All experiments were carried
out in accordance with Animals (Scientific Procedures) Act
1986 under project license 30/2816 issued byUKHomeOffice.
This study was approved by Jinling Hospital Research Ethics
Committee. C57BL/6 mice were housed in a temperature-
controlled environment (22 ± 0.5∘C) with a 12-h light-dark
cycle and allowed free access to food and water. All efforts
were made to minimize animal suffering and reduce the
number of animals used. The NSCs were dissected from
embryonic brain tissue of E14 day C57BL/6 mice (mice
were provided by Model Animal Research Centre of Jingling
Hospital Nanjing, Jiangsu, China). Briefly as described pre-
viously [11], the brain tissue was transferred into ice bathed
DMEM/F12 medium for meninx and vessel tissue removal.
The brain tissue was then digested by Accutase. The single-
cell suspensionwas collected and resuspended inDMEM/F12
medium containing B27, bFGF, and EGF.The cell culture was
kept in at 37∘C, 5% CO
2
. Changing culturing medium was
done every three days. Passage of the NSCs was performed as
the neurospheres grew to 50–100 𝜇m diameter.
2.3. NSCs Oxidative Stress Induction. The neurosphere cul-
ture was digested into single-cell suspension and seeded
on the PDL precoated cover glass, dish, or 6-well plates,
depending on further test. The NSCs were cultured at 37∘C,
5% CO
2
overnight. As far as the single cell of NSCs attached,
change the medium with DMEM/F12 medium without B27,
EGF, and bFGF for cell starving, preparing the following
oxidative stress induction.
Following 2 h starving, 50, 100 (final applied moderate
concentration for modelling), 200, and 400𝜇M H
2
O
2
were,
respectively, added toDMEM/F12, culturing for further 2 h as
the oxidative stress induction, to choose the final modelling
dosage. DMEM/F12 medium without any supplements was
used as the vehicle control.
2.4. NSCs Treatment. For the signalling inhibitor pretreat-
ment, after the cell starving, 0.5 𝜇M (final concentration) GA
and 8 𝜇M (final concentration) JSH-23 were administrated,
respectively, to the monolayer NSCs for 1 h, before the
oxidative stress induction. DMSO was used as the cosolvent,
with the final concentration of 0.1%. DMEM/F12 medium
containing 0.1% DMSO was used as the vehicle control.
2.5. Cellular Detection. The cell viability was assessed with
MTT assay as previously described [10]. The intracellular
reactive oxygen production was detected with the DCFH-
DA probe dye, according to the manuscript’s instructions.
The apoptosis and cell death assessment were detected with
Annexin V-FITC/PI kit following the manuscript’s instruc-
tions.
2.6. Immunofluorescence (IF). The NSCs were fixed with 4%
paraformaldehyde (Sigma-Aldrich, MO, USA) and perme-
abilized with 0.1% Triton X-100 (Sigma-Aldrich, MO, USA).
After blocking the nonspecific proteins with 3% BSA-PBS
solution, the fixed cells were then incubated with anti-HSP90
and anti-phospho-p65 over night at 4∘C. The cells were
transferred to FITC/TRITC-conjugated secondary antibod-
ies (Cell Signalling Technology, MA, USA), incubating for
1 hour. Fluorescence data was collected with fluorescence
microscope and analyzed with ImageJ software.
2.7.Western Blotting. Thecell lysatewas collected fromNSCs.
The sample loadings were subjected onto 12% SDS-PAGE
gel for electrophoresis as previously described with slight
modification [10]. The protein bands were transblotted onto
PVDFmembrane (Millipore, OH,USA), being blocked in 5%
BSA-TBST buffer and incubated with the primary antibodies
and HRP-conjugated secondary antibodies. The antigen-
antibody complexes were then detected with an ECL reagent
kit (Millipore, OH,USA), and developedwith X-ray film.The
protein band density was analyzed with ImageJ software.
2.8. Statistical Analysis. We evaluated the statistical sig-
nificance using independent-samples t-tests, followed by
ANOVA tests when the data involved three or more groups.
Results are presented as means ± SD. P < 0.05 was considered
to be significant.
3. Results
3.1. Culture of Neural Stem Cells. The NSCs were dissected
from embryonic mouse at E14 and cultured to form the
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Figure 1: Identification of NSCs. Immunofluorescence identification of neurosphere and monolayer culture of NSCs with anti-Nestin. Scale
bar: 20 𝜇m.
neurospheres in flasks. For cell identification, immunofluo-
rescence targeting at the Nestin was applied (Figure 1). As
the result demonstrated, up to ∼95% cells were detected as
Nestin-positive NSCs.
3.2. Oxidative Stress Induced Cell Death in Neural Stem Cells.
The monolayer culture of NSCs was subjected to 100 𝜇M
H
2
O
2
treatment for 2 h. After oxidative stress induction,
the cell morphology, MTT assay, DCF-DA, and Annexin V-
FITC/PI staining were applied to assess the cell injury.
According to the results with 50, 100, 200, and 400 𝜇M
H
2
O
2
treatment (Figure 2(a)), the injury with 100 𝜇M H
2
O
2
was the moderate dosage to NSCs (cell viability proportion
dropped to 50.2 ± 6.3%). While 50 𝜇M H
2
O
2
induced a
very light injury, 200 and 400 induced too heavy damage of
NSCs to death, which are not the proper dosages for model
establishment in this study. Therefore, dosage of 100𝜇M was
applied in the following experiments. With the morphology
result (Figure 2(b)), the control NSCs displayed healthy cell
morphology with bright and smooth cell body and extended
neural synapses, while the injured NSCs by 100 𝜇M H
2
O
2
treatment demonstrated broken cytomembrane, wizened cell
body, and synapses, indicating an unhealthy status. DCF-
DA staining demonstrated obviously more ROS production
in H
2
O
2
treatments NSCs, comparing to that in control
NSCs (Figure 2(c)). While for Annexin V-FITC/PI assay
(Figure 2(d)), 44% of the H
2
O
2
injured NSCs were positively
stained by Annexin V-FITC indicating an early stage apop-
tosis, which was significantly higher than that with control
NSCs at a normal level of 22%; 20% of the injured NSCs
demonstrated double staining by Annexin V-FITC and PI
staining, also notably greater than that with the control NSCs
at 6%; 27% of the injured NSCs were stained by PI indicating
later stage of cell death, while the proportion in control
NSCs was only 4%.The assay demonstrated a 9% healthy cell
proportion in the H
2
O
2
treatments NSCs, comparing with
which was significantly higher in control NSCs, up to 68%
(Figure 2(e)).
Taken together, these results suggested a significant dam-
age on in vitro culturedNSCs by 100 𝜇MH
2
O
2
treatment.The
injury produced could be due to the oxidative stress induced
apoptosis and cell death.
3.3. Oxidative Stress Triggered the Activation of HSP90 and
NF-𝜅B/p65. To address the underlying molecular mecha-
nism of cell survival of NSCs from oxidative stress induced
apoptosis and cell death, the role of HSP90 and NF-𝜅B/p65
in the pathology was investigated.
With oxidative stress injury by H
2
O
2
administration,
the protein expression of HSP90 significantly boosted up
to 1.7-fold higher than that in control NSCs (Figure 3(a)).
Consistently, as immunofluorescence demonstrated, HSP90
displayed a mainly cytoplasmic distribution in control NSCs.
The nucleus around expression was observed only within a
small number of cells while a significant centralized expres-
sion of HSP90 around the nuclei was detected in greater
number of the NSCs treated by H
2
O
2
(Figure 3(b)). The
results indicated an involvement of HSP90 in NSCs survival
against oxidative stress injury.
As for NF-𝜅B/p65, the H
2
O
2
administration induced
significantly upregulation on both total p65 and nuclear
phospho-p65, while the protein in control NSCs maintained
on regular level (Figure 3(c)). The immunofluorescence also
demonstrated an increased nuclear distribution of phospho-
p65 afterH
2
O
2
administration, comparingwith controlNSCs
(Figure 3(d)). These data suggest a notable activation of NF-
𝜅B/p65 in NSCs survival against oxidative stress injury.
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Figure 2: NSCs survival from oxidative stress induced by H
2
O
2
treatment. The NSCs were subjected to 100 𝜇M H
2
O
2
induction for 2 h,
following cell starving within the DMEM/F12 medium without B27, EGF, and bFGF.The NSCs treated with the vehicle medium were used as
control. (a)The cell viability byMTT assay of the NSCs. (b)The cell morphology of the NSCs. (c)The ROS production of the NSCs probed by
DCF-DA. (d) The apoptosis and cell death of the NSCs detected by Annexin V-FITC/PI kit. (e) Quantified positive cell number of the NSCs
with Annexin V-FITC/PI staining. ∗∗𝑃 < 0.01 was considered to be significantly different between control and H2O2 groups.
3.4. Geldanamycin Blocked Oxidative Stress Triggered NF-
𝜅B/p65 Activation. Since both HSP90 and NF-𝜅B/p65 were
involved in oxidative stressed injured NSCs, to determine
their streaming relationship, pharmacological inhibitors tar-
geting at the two signalling proteins were applied.
As the specific inhibitor of HSP90, the pretreatment
of 0.5𝜇M GA significantly abolished the H
2
O
2
-induced
upregulation on phospho-IKK, phospho-I𝜅B, and nuclear
phosphor-p65, which suggested a deactivating effect on NF-
𝜅B/p65 activation (Figures 4(a)–4(c)).
3.5. JSH-23 Failed in Blocking the Oxidative Stress Triggered
HSP90 Activation. While with the pretreatment 8 𝜇M JSH-
23, the inhibitor of NF-𝜅B/p65, the H
2
O
2
-induced upregu-
lation on HSP90 in NSCs maintained with the augmented
expression level [12], indicating a failed regulation of the
NF-𝜅B/p65 inhibitor on triggered HSP90 in oxidative stress
injured NSCs (Figure 4(d)).
3.6. Induced Colocalization of HSP90 and NF-𝜅B/p65 in
Oxidative Stress Injured Neural Stem Cells. According to the
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Figure 3: H
2
O
2
triggers HSP90 and NF-𝜅B/p65 activation. (a) and (c)The protein expression of HSP90, nuclear phospho-p65, and total p65
in the NSCs induced by H
2
O
2
induction. (b) and (d) The intracellular distribution of HSP90 and the nuclear translocation of phospho-p65
in the H
2
O
2
induced NSCs. The protein expression and intracellular distribution in NSCs cultured within the vehicle medium were used as
control. ∗𝑃 < 0.05 and ∗∗𝑃 < 0.01 were considered to be significantly different between control and H2O2 groups. n = 3.
results from both inhibitors, HSP90 could potentially work as
an upper-stream signalling over NF-𝜅B/p65 in the survival of
NSCs from H
2
O
2
-induced neural oxidative stress.
Further investigation with GA demonstrated that, in
contrast with the cytoplasmic distribution of HSP90 and
nuclear expression of p-p65 at a low level in control NSCs,
theH
2
O
2
-injuredNSCs displayed a dramatic upregulation on
p-p65 nuclear translocation, as well as a significant augment
on HSP90 and p-p65 colocalization at nuclei (Figure 5). This
diploid activation on HSP90 and nuclear p-p65 under H
2
O
2
induction in NSCs was obviously abolished by pretreatment
of GA, the inhibitor of HSP90. The protein distribution of
HSP90, especially around the nuclei, was attenuated, while
the nuclear translocation of p-p65 was notably decreased.
Therefore, the colocalization of HSP90 and p-p65 was partly
abolished by GA pretreatment (Figure 5).
The results indicated that as far as HSP90 activity was
inhibited by GA, NF-𝜅B/p65 signalling was blocked as an
effector. HSP90 activity performed as an upper-stream sig-
nalling of NF-𝜅B/p65 under H
2
O
2
induction.
3.7. Protective Effect of Geldanamycin on Oxidative Stress
Injured Neural Stem Cells. With the determination of upper-
stream role of HSP90 over NF-𝜅B/p65, we further mean
to confirm the function of HSP90 in NSCs survival from
oxidative stress induced cell death.
Both Hoechst/PI double staining andMTT assay demon-
strated the neuroprotective effect of GA pretreatment against
H
2
O
2
-injury. With the Hoechst straining as a cell count, the
PI staining positive cells were considered as the damaged
NSCs, whose number was obviously decreased with GA
treatment, followed by H
2
O
2
-injury; the cell viability was
6 Oxidative Medicine and Cellular Longevity
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Figure 4: Effect of Geldanamycin and JSH-23 on H
2
O
2
induced NF-𝜅B/p65 and HSP90 activation. The pretreatment of 0.5𝜇MGA or 8𝜇M
JSH-23 was administrated to NSCs for 1 h, followed by the H
2
O
2
induction. (a)–(c) The protein expression of phospho-IKK, total IKK,
phospho-I𝜅B, total I𝜅B, nuclear phospho-p65, and total p65 in the NSCs treated with GA and H
2
O
2
. (d) The protein expression of HSP90 in
the NSCs treated with JSH-23 and H
2
O
2
. The protein expression in NSCs cultured within the vehicle medium was used as control. ∗𝑃 < 0.05
and ∗∗𝑃 < 0.01 were considered to be significantly different between control and H2O2 or between H2O2 and GA/JSH-23+H2O2 groups. n =
3.
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Figure 5: Effect of Geldanamycin on the colocalization in the H
2
O
2
induced NSCs. (a)The protein distribution and colocalization of HSP90
and NF-𝜅B/p65 in control, H
2
O
2
induced, and GA+H
2
O
2
induced NSCs. (b) Percentage of phospho-p65 nuclear translocation in control,
H
2
O
2
induced, and GA+H
2
O
2
induced NSCs. (c) Percentage of colocalization of HSP90 and NF-𝜅B/p65 in control, H
2
O
2
induced, and
GA+H
2
O
2
induced NSCs. ∗∗𝑃 < 0.01 was considered to be significantly different between control and H2O2 groups or between H2O2 and
DA+H
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2
groups. n = 3.
rescued from 46.7 ± 7.5% to 65.6 ± 6.3% with GA treatment,
in previous of H
2
O
2
-injury (Figure 6).
The results suggested a neuroprotection of inhibiting
HSP90 with GA on NSCs survival from oxidative stress.
4. Discussion
As the stem cell transplantation arising as a potential therapy
for serials of CNS disease [2], the cell survival of engrafted
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induction.The NSCs treated with the vehicle medium were used as control. (a)The cell death of each group of NSCs detected by
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groups. n = 3.
stem cells after transplantation has become a vital limitation
to the therapy outcome and further application [4]. The
engrafted stem cells always face very complicated patho-
logical condition, such as oxidative stress, inflammation,
and immune response, among which oxidative stress could
play a primary role [9, 13]. A range of CNS pathologies,
such as neurodegenerative diseases and neural trauma, are
symbolized as oxidative stress, following the overbalanced
ROS production [6, 9]. The oxidative stress consequently
induces the cell damage around the lesion area, as well as
the engrafted stem cell. To overcome the neural oxidative
stress and rescue the engrafted stem cell, investigation on
the mechanism underlying stem cell survival from oxidative
stress is quite needed. Our previous study has revealed that
H
2
O
2
could damage the neuronal cell line and PC12 cells
at concentration of 400 𝜇M [10]; the ischemia/reperfusion
injury, of which oxidative stress plays a crucial role, causes
different types of cell death on neurons, including apoptosis
and autophagy [8].However, the study onNSCs survival from
H
2
O
2
-induced oxidative stress and its underlyingmechanism
have rarely been reported before. In this study, we modelled
the oxidative stress injured NSCs with 100 𝜇M H
2
O
2
induc-
tion. The oxidative induction notably increased the ROS
production, detected by DCF-DA probe method. And the
induction damaged the NSCs to apoptosis, even cell death,
mimicking the NSCs survival in pathological environment
for transplantation therapy.
Concerning the involved signalling mechanism of neural
injury by oxidative stress, NF-𝜅B is normally listed as the
first candidate [14, 15]. It was confirmed by our results that
when induced oxidative stress happens in NSCs, NF-𝜅B is
activated through IKK/I𝜅B/p65 cascaded phosphorylation.
The phospho-p65 in consequence is released from the com-
plex with I𝜅B and translocates into nucleus for relative gene
transcription, which finally leads to DNA damage, signalling
overactivation, and cell death. It can be considered that NF-
𝜅B/p65 is involved in NSCs damage by oxidative. However, it
is still too far away from concluding it as the very mechanism
underlying the NSCs survival from oxidative stress.
We furthermove our focus toHSP90, a chaperone protein
that facilities other proteins folding properly, stabilizes pro-
tein against stimulations, and rescues protein from degrada-
tion [16]. HSP90 is normally required for protein stabilization
essential to tumour progress [16]. Therefore, the protein is
always considered as a drug target for cancer therapy and
research [17]. However, the function of HSP90 involved in
neural damage and cellular oxidative stress is rarely reported
wildly. Here, in this study, along with the activation of
NF-𝜅B/p65 during the neural oxidative pathology, HSP90
was also triggered through upregulated protein expression
and centralized distribution around nucleus. Moreover, the
oxidative induced NSCs displayed an increased colocaliza-
tion of HSP90 and NF-𝜅B/p65, comparing to the normal
control NSCs, which suggest a cofactor relationship between
the two signalling proteins on mediating oxidative stress in
NSCs [18]. Previous reports described the relationship in
several other pathologies as a requirement of HSP90 for
IKK biosynthesis and induced NF-𝜅B activation [19] or an
inhibition on NF-𝜅B/p65 by the HSP90 inhibitor [20]. To
further determine the streaming relationship between the
two signalling proteins, we applied their pharmacological
inhibitor on each other. According to our results, the HSP90
inhibitor [21], GA, blocked the induced IKK/I𝜅B/p65 acti-
vation, while the NF-𝜅B/p65 inhibitor [12], JSH-23, failed
in inhibiting HSP90 upregulation when oxidative stress
happens in NSCs. It suggested an upper-stream role of
HSP90 to NF-𝜅B/p65 in NSCs oxidative stress. The require-
ment of HSP90 for NF-𝜅B/p65 could not happen as late
until p65 phosphorylation but potentially starts as early
as IKK and I𝜅B activating stage, according to the effect
of GA on the two upper-stream kinases of NF-𝜅B/p65.
The decreased nuclear translocation of phospho-p65 and
attenuated colocalization of phospho-p65 and HSP90 by GA
administration followed by oxidative injury, in consistency
further confirming the role of HSP90 upon NF-𝜅B/p65
activation under the pathology. As far as was determined by
the relationship between HSP90 and NF-𝜅B/p65 oxidative
injury, our data usingGAonNSCs suggested a rescuing effect
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Figure 7: Diagram of HSP90/NF-𝜅B pathway of NSCs survival from oxidative stress.The cell death inducing oxidative stress triggers HSP90
to activate IKK/I𝜅B/p65 pathway and damage NSCs to apoptosis and death. The inhibition on HSP90 from neural oxidative induction will
block the NF-𝜅B/p65 signalling activation and rescue the NSCs from oxidative damage.
through HSP90 inhibition from oxidative stress induced cell
death.
In conclusion, taking together the above results, it is
believed that the cell death inducing oxidative stress could
trigger IKK/I𝜅B/p65 activation through HSP90 and induce
NSCs damage. The inhibition on HSP90 activity from neural
oxidative stress will block the NF-𝜅B/p65 signalling activa-
tion and promote the NSCs survival (Figure 7). The pro-
tecting effect on NSCs in oxidative stress and its underlying
signalling mechanism including HSP90 and NF-𝜅B/p65 that
we reveal in this study provides some more data on NSCs
survival from oxidative stress and also promotes the stem cell
study and application on CNS pathology.
Additional Points
Highlights. (1) HSP90 and NF-𝜅B/p65 activation are involved
in oxidative stress induced NSCs damage. (2) HSP90 plays as
an upper-stream signalling of NF-𝜅B/p65 in NSCs survival
from oxidative stress induced damage. (3) Inhibiting HSP90
promotes NSCs survival from oxidative stress induced dam-
age through attenuating NF-𝜅B/p65 activation.
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